Authors:
Schroder, LE
Lew, D
Flanigan, RC
Eisenberger, MA
Seay, TE
Hammond, N
Needles, BM
Crawford, ED
Citation: Le. Schroder et al., Phase II evaluation of suramin in advanced renal cell carcinoma - A Southwest Oncology Group study, UROL ONCOL, 6(4), 2001, pp. 145-148
Authors:
Kaiser, L
Morabia, A
Stalder, H
Ricchetti, A
Auckenthaler, R
Terrier, F
Hirschel, B
Khaw, N
Lacroix, JS
Lew, D
Citation: L. Kaiser et al., Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis, EUR J CL M, 20(7), 2001, pp. 445-451
Citation: R. Perez-hernandez et D. Lew, Biogeographical classifications and hypotheses for the Venezuelan Guayana, INTERCIENCI, 26(9), 2001, pp. 373-382
Authors:
Abraham, E
Laterre, PF
Garbino, J
Pingleton, S
Butler, T
Dugernier, T
Margolis, B
Kudsk, K
Zimmerli, W
Anderson, P
Reynaert, M
Lew, D
Lesslauer, W
Passe, S
Cooper, P
Burdeska, A
Modi, M
Leighton, A
Salgo, M
Van der Auwera, P
Citation: E. Abraham et al., Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients, CRIT CARE M, 29(3), 2001, pp. 503-510
Authors:
Small, EJ
Lew, D
Redman, BG
Petrylak, DP
Hammond, N
Gross, HM
Eastham, JA
Crawford, ED
Citation: Ej. Small et al., Southwest oncology group study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: The importance of survival as a clinical trialend point, J CL ONCOL, 18(13), 2000, pp. 2537-2544
Authors:
Ricchetti, A
Lacroix, JS
Kaiser, L
Morabia, A
Stalder, H
Auckenthaler, R
Terrier, F
Hirschel, B
Khaw, N
Lew, D
Citation: A. Ricchetti et al., Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute sinusitis, SCHW MED WO, 130(49), 2000, pp. 27S-29S
Authors:
Sinha, B
Francois, P
Que, YA
Hussain, M
Heilmann, C
Moreillon, P
Lew, D
Krause, KH
Peters, G
Herrmann, M
Citation: B. Sinha et al., Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells, INFEC IMMUN, 68(12), 2000, pp. 6871-6878
Authors:
Elias, L
Lew, D
Figlin, RA
Flanigan, RC
Thompson, ME
Triozzi, PL
Belt, RJ
Wood, DP
Rivkin, SE
Crawford, ED
Citation: L. Elias et al., Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma - A southwest oncology group phase II study, CANCER, 89(3), 2000, pp. 597-603
Authors:
Williamson, SK
Lew, D
Miller, GJ
Balcerzak, SP
Baker, LH
Crawford, ED
Citation: Sk. Williamson et al., Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma - A Southwest Oncology Group study, CANCER, 88(5), 2000, pp. 1159-1165
Authors:
Martin, T
Parker, SE
Hedstrom, R
Le, T
Hoffman, SL
Norman, J
Hobart, P
Lew, D
Citation: T. Martin et al., Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection, HUM GENE TH, 10(5), 1999, pp. 759-768
Authors:
Zanetti, G
Harbarth, SJ
Trampuz, A
Ganeo, M
Mosimann, F
Chautemps, R
Morel, P
Lew, D
Zimmerli, W
Lange, J
Glauser, M
Citation: G. Zanetti et al., Meropenem (1.5g/day) is as effective as imipenem/cilastatin (2g/day) for the treatment of moderately severe intra-abdominal infections, INT J ANT A, 11(2), 1999, pp. 107-113
Citation: Yl. Chang et al., Biomechanical and morphometric analysis of hydroxyapatite-coated implants with varying crystallinity, J ORAL MAX, 57(9), 1999, pp. 1096-1108
Authors:
Lew, D
DeWitt, A
Hicks, RJ
Cavalcanti, MGP
Citation: D. Lew et al., Osteomas of the condyle associated with Gardner's syndrome causing limitedmandibular movement, J ORAL MAX, 57(8), 1999, pp. 1004-1009
Authors:
Jaccard, C
Troillet, N
Harbarth, S
Zanetti, G
Aymon, D
Schneider, R
Chiolero, R
Ricou, B
Romand, J
Huber, O
Ambrosetti, P
Praz, G
Lew, D
Bille, J
Glauser, MP
Comett, A
Citation: C. Jaccard et al., Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (vol 42, pg 2966, 1998), ANTIM AG CH, 43(3), 1999, pp. 726-726
Authors:
Meyers, FJ
Lew, D
Lara, PN
Williamson, S
Marshall, E
Balcerzak, SP
Rivkin, SE
Samlowski, W
Crawford, ED
Citation: Fj. Meyers et al., Phase II trial of edatrexate in relapsed or refractory germ cell tumors: ASouthwest Oncology Group study (SWOG 9124), INV NEW DR, 16(4), 1998, pp. 347-351
Authors:
Samlomski, WE
Lew, D
Kuebler, PJ
Kolodziej, MA
Medina, JE
Mangan, KF
Moore, DF
Schuller, DE
Ensley, JF
Citation: We. Samlomski et al., Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study, INV NEW DR, 16(3), 1998, pp. 271-274